figura a figura b

Injectable forms under contract to the world

Instituto Biológico Contemporáneo S.A. (IBC) is a company of Argentine capital exclusively dedicated to the elaboration of injectable medicinal specialties for the national and international pharmaceutical industry..

Services

Elaboration to Third Parties

Laboratorio Instituto Biológico Contemporáneo S.A (IBC) provides production services for the following sterile pharmaceutical forms:

Lyophilized
  • • Acyclovir 500 mg / 250 mg
  • • Amphotericin B 50 mg
  • • Clarithromycin 500 mg
  • • Diliazem 25 mg
  • • Esomeprazole 40 Mg
  • • Ganciclovir 500 mg
  • • Hydrocortisone 100 mg / 250 mg / 500 mg
  • • Ibuprofen 400 mg
  • • Indomethacin 50 mg
  • • Calcium Leucovorin 50 mg
  • • Methylprednisolone 500 mg / 1g
  • • Sodium Nitroprusside 50 mg
  • • Omeprazole Sodium 40 mg
  • • Sodium Pamindronate 30 mg / 60 mg / 90 mg
  • • Pantoprazole 40 mg
  • • Pridinol 2 mg / 400 mg
  • • Piroxicam 20 mg
  • • Remifentanil 1 mg, 2 mg, 5 mg
  • • Succinylcholine 100 mg / 500 mg
  • • Teicoplanin 200 mg / 400 mg
  • • Vancomycin 500 mg
  • • Vecuronium Bromide 4 mg / 10 mg
  • • Vitamin B12 10 mg / 20 mg
  • • Interferon Alpha 2a / 2b
Injectable Solutions
  • • Amikacin 100 mg / 250 mg / 500 mg
  • • Atracurium 50 mg
  • • Betamethasone 4 mg / 1ml
  • • Bupivacaine HCl 5%
  • • Ciprofloxacin 2 mg / 100 ml
  • • Clindamycin 300 mg / 600 mg
  • • Lysine Clonixinate
  • • Dobutamine 250 mg / 20 ml
  • • Dexamethasone Sodium Phosphate 4 mg / ml
  • • Diclofenac Na 75 mg / 3 ml
  • • Diclofenac K 75 mg / 5 ml
  • • Diazepam 10 mg / 2 ml
  • • Dipyrone 2.5 gr / 5 ml
  • • Erythropoietin 1000 IU / 2000 IU / 4000 IU
  • • Ethylephrine HCll 10 mg
  • • Filgrastim 300 mcg / 480 mcg
  • • Fluconazole 2mg / ml * 100ml
  • • Sodium Heparin 10,000 IU
  • • Nalbuphine 10 mg
  • • Levofloxacin 500 mg
  • • Lidocaine 1% and 2%
  • • Lidocaine with Epinephrine
  • • Midazolam 5 mg / 15 mg
  • • Ranitidine 50 mg
  • • Pancuronium Bromide 4 mg / 2 ml
  • • Ondansetron 4 mg / 8 mg
  • • Tramadol HCl 100 mg
  • • Vit. B1, B12 (Vit. B1, B6, B12)
  • • Sol. Chlorinated
  • • Sol. Glucose
  • • Sol. Physiological (0.9% P / V sodium chloride solution)
Sterile powders (Beta-lactams and Carbapenems)
  • • Ampicillin 500 mg / 1000 mg
  • • Amoxicillin 1g / 500 mg
  • • Amoxicillin + Clavulanic 600 mg / 1.2 g
  • • Ceftriaxone 1 g
  • • Ceftazidime 1 g
  • • Ampicillin + Sulbactam 1.5 g
  • • Cephalothin Sodium 1g
  • • Cefotaxime 1g
  • • Cefazolin 1g
  • • Cefoperazone 1g
  • • Piperacillin + Tazobactam 4.5 g
  • • Meropenem 500 mg / 1g
  • • Imipenem + Cilastatin 500 mg
  • • Cefepime + L-Arginine (1 g - 0.750 mg)
  • • Cefepime + L-Arginine (2 g - 1,450 g)

Essays

TOC test

Among the services we offer is the TOC test. Both for purified water and for water for injection and in cleaning validation studies developed using this technique.

Subvisible Particle Test (F.A)

Light blocking test for water-based samples.

At the customer's request, our services include the secondary conditioning of the product.

gmp
anmat
mercosur
invima

Institutional

Instituto Biológico Contemporáneo S.A. (IBC) is a company of Argentine capital exclusively dedicated to the elaboration of injectable medicinal specialties for the national and international pharmaceutical industry


 Since its foundation in the Autonomous City of Buenos Aires in 1989, IBC has developed a policy based on growth and continuous improvement.


 The current Pharmaceutical Plant is located in the District of Ituzaingo, province of Buenos Aires. It has an area of 12,650 m2 of which 7,500 m2 are covered.


 Our pharmaceutical plants are equipped with the latest technology. One of them on 2,900 m2 covered, dedicated to the production of lyophilized products and injectable solutions in ampoules and ampoule bottle of general assets and the other segregated plant on 2,000 m2 for the exclusive production of injectable products in the form of sterile beta-lactam powders.


 In the central building of 1,400 m2 covered in addition to the production plant of general assets, there are the offices of the Board of Directors, and the Administrative, Planning, HR, Regulatory Affairs, Quality and Technical Management. Physically separated with a covered area of 1,500 m2 are located the warehouse for raw materials and finished products and general supplies and the areas of revision and conditioning. The antibiotic products manufacturing plant is located in a separate building of 2,000 m2 covered and on the first floor with a clear separation of the antibiotics plant with an area of 440 m2 covered are located the Department of Quality and Microbiological Control and the Galenic Department and Analytical Development.


 IBC has had since its inception the constant vocation to provide excellence in quality in all its pharmaceutical services. IBC has a staff of highly trained professionals, in addition to having machinery, facilities and necessary instruments that allow it to carry out its activity under strict GMP (Good Manufacturing Practices) and GLP (Good Laboratory Practices) standards, which govern our activity. pharmaceutical. For this, IBC, since 1997 has developed an Investment Plan in equipment and facilities that have allowed it to optimize responses for its market in Latin American and Asian countries, currently having local, ANMAT, and international certifications such as MERCOSUR and INVIMA (Colombia).

Production plant

The plant has a module dedicated exclusively to the production of injectables with general assets in lyophilized injectable pharmaceutical forms and solution in a covered area of 2,900 m2. For this, it has two freeze-drying equipment with a capacity of 150 liters with productions between 7,000 and 26,000 units, two new freeze-drying equipment with a capacity of 300 liters for the manufacture of between 20,000 and 65,000 units, and a modern dosing equipment for injectable solutions with capacities between 4,000 and 18,000 units hours. The latter two are equipped with a continuous production line with a washing / depyrogenating / dosing tunnel for bottles and ampoules that ensure the aseptic quality of the product at high production levels.

The plant for the preparation of sterile and lyophilized injectable solutions have areas classified according to international quality standards and state-of-the-art automatic equipment.The segregated plant for beta-lactam and carbapenemic antibiotics has a covered area of 2,000 m2 and has a continuous production line of washing / depyrogenation / dosing / checking and packaging of sterile powders that guarantee optimal levels of production for a production of 10,000 units hours

Annual production capacity

Ampoules 24 million units
Liquid Vials 50 million units
Lyophilized 10 million units
Β-lactam Antibiotic Powders 16 million units
Βiological 50 million units

Production lines

Module 1

Freeze Dried Powders and Solutions in Vials

150 liters of condensate capacity, installed in an aseptic area with high-efficiency filters and individual sealing area

Module 2

Freeze Dried Powders and Solutions in Vials

300 liters that are part of a continuous and fully automatic line for dosing, loading and unloading of vials and sealing, performing all operations under cabinets equipped with high-efficiency filters

Ampoules Line

Fully automatic continuous area achieves a capacity of more than 18,000 units per hour, with high-efficiency filters

Beta-lactams

8,000 units per hour vial dispenser, which is part of a continuous and fully automatic dispensing line under cabinets equipped with high-efficiency filters

Contact

Enter your name.
Enter your email.
Enter your comments.

International market

laboratorio ibc

IBC Laboratory offers its services internationally For more information: contact us

Job opportunities

At IBC we have various job opportunities for all of our areas. Attach your CV in Word or PDF format with your contact details

(máx: 2mb) (PDF, XLS, XLSX, DOC, DOCX, JPG, PNG & GIF).
Upload a CV (máx: 2mb) (PDF, XLS, XLSX, DOC, DOCX, JPG, PNG & GIF).